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1. Introduction 
Stem cells are a rare population of cells that have the ability to self-renew (to replenish the 
stem cell pool) and to differentiate (to produce daughter cells that will perform the 
physiological functions of tissues and organs). Although stem cells exist in different tissues, 
organs, and developmental stages. However, stem cells differ to some degree with regard to 
their developmental potency; life span, and notably their potential for self-renewal and 
proliferation capacity. 
Stem cell self-renewal and differentiation is regulated by signaling pathways, transcription 
factors, and micro RNAs (miRNAs). Some key transcription factors directly regulate the 
expression of miRNAs in stem cells. Meanwhile, miRNAs target key transcription factors 
and either repress or induce their expression in stem cells to regulate self-renewal and 
differentiation. Thereby, the miRNA regulatory network and the signaling pathways cross-
talk to each other to orchestrate stem cell maintenance and cell fate decision. Dysregulation 
of core signaling pathways, transcription factors and miRNAs associated with normal stem 
cells can lead to carcinogenesis. Thus, understanding the regulation of normal stem cell is 
crucial for understanding the molecular mechanisms underline carcinogenesis. 
In this chapter, we review the characteristics and functions of miRNAs and cancer stem cells 
(CSCs), focusing on the roles of miRNAs in regulating CSCs. First, we provide an 
introduction to stem cells and CSCs. Then, we describe the signaling pathways that regulate 
stem cell self-renewal and differentiation. In particular, we review the Wnt/ǃ-catenin, 
Hedgehog (HH), and Notch pathways. Next, we discuss the epithelial–mesenchymal 
transition (EMT), CSCs, and miRNAs that play roles in regulating stem cells. Finally, we 
summarize the current status and discuss future perspectives. 
2. Stem cells 
Depending on their differentiation potentials, human stem cells can be classified into 
totipotent, pluripotent, and multipotent (http://stemcells.nih.gov/info/scireport). 
Totipotent cells have the potential to form any of the differentiated cells in a living 
organism from a single cell. Thus, these cells have ability to form extraembryonic 
membranes and tissues; the embryo itself, and all postembryonic tissues and organs. At the 
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very early stage of embryo development, each cell in the blastomere is totipotent. 
Pluripotent cells can differentiate to form tissues of any of the three germ layers: ectoderm, 
endoderm, or mesoderm. However, a pluripotent cell cannot form an entire living organism. 
Embryonic stem cells (ESCs) are pluripotent stem cells derived from the inner cell mass of 
the human blastocyst. ESCs can differentiate into specialized cells, and have an unlimited 
capacity for self-renewal. Multipotent cells—adult stem cells—have a differentiation ability 
that is limited to a specific tissue- or organ. Tissue-specific adult stem cells are responsible 
for organogenesis; tissue maturation, repair and regeneration, and maintenance; and 
balancing the cellular turnover. To fulfill these responsibilities; first, an adult stem cell is an 
undifferentiated cell that is found in a differentiated tissue and has the capacity to become 
specialized to yield all of the cell types of the tissue from which it originated; second, a stem 
cell has capacity to self-renewal (Spradling et al., 2001). They can undergo two kinds of cell 
division: symmetric and asymmetric. In symmetric division, a stem cell divides into two 
identical daughter cells, which are both identical to the originating stem cell. This type of 
division is crucial for expanding the stem cell pool, most likely in very early embryonic 
development. In contrast, in asymmetric division, a stem cell divides into one daughter 
progenitor cell (also known as a precursor cell), which eventually differentiates into a 
mature cell, and one new stem cell, which is identical to the originating stem cell. This 
process maintains stem cell number, and this feature also distinguishes the stem cell self-
renewal from other proliferative processes. Normal adult stem cell can divide 
asymmetrically to maintain the population of stem cells and differentiated cells. The 
processes that regulate the balance between asymmetric and symmetric division of stem 
cells are unclear. 
A progenitor cell is a partially specialized cell that can divide and yield two specialized 
cells. Progenitor cells can be distinguished from adult stem cells as follows. When a stem cell 
divides, at least one of the two new cells is always identical to the originating stem cell and 
can replicate itself. In contrast, when a progenitor cell divides, it gives rise to two progenitor 
cells or two specialized cells, neither of which can replicate itself. Progenitor cells can 
replace cells that are damaged or dead, thereby maintaining the integrity and functions of a 
tissue or an organ such as the liver or the brain. Examples of stem and progenitor cells: 
• Hematopoietic stem cells (adult stem cells) from the bone marrow that give rise to 
erythrocytes, lymphocytes, plateles, monocytes, and granulocytes. 
• Mesenchymal stem cells (MSCs) are a subset of nonhematopoietic multipotent stem 
cells (adult stem cells) that are found primarily within the bone marrow and give rise to 
stromal cells; within the adipose tissue that give rise to adipocytes (Bieback et al., 2008; 
Digirolamo et al., 1999). MSCs have also been isolated from the umblical cord (fetal 
stem cells). Mesenchymal stem cells can self-renew and are defined as cells that 
differentiate into a variety of mesenchyme-derived cell types: fibroblasts, chondrocytes, 
osteoblasts, myoblasts, and neural stem cells; the latter cells have the potential to 
differentiate into neurons, astrocytes, and oligodendrocytes (Barry and Murphy, 2004; 
Halleux et al., 2001). 
• Epithelial stem cells (progenitor cells) that give rise to the various types of skin cells. 
• Muscle stem cells that give rise to differentiated muscle tissue. 
• Intestinal stem cells. 
On the other hand, accumulating data show that different stem cells have distinct potential to 
proliferate, and some adult stem cells from one tissue are capable of differentiating into the 
specialized cell types of another tissue (Herzog et al., 2003; Krause, 2002a). This phenomenon 
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is referred to as stem cell plasticity. For example, under specific experimental conditions, adult 
stem cells from bone marrow can differentiate into cells that resemble neurons (Herzog et al., 
2003; Krause, 2002a). Growing evidence indicates that, given the right environment 
(environmental niche), some adult stem cells are capable of being genetically reprogrammed to 
differentiate into tissues other than the ones from which they originated. 
Regardless of division type, stem cell self-renewal is especially important in tissues with 
high self-renewal capacity, such as the intestinal cells and bone marrow, and also in tissue 
repair after injury. Adult tissues that undergo turnover throughout life are maintained via a 
very small portion of cells—adult stem cells that live through the entire life span of an 
organism. These stem cells can maintain homeostasis even in mitotically inactive adult 
tissues, such as the brain (Bartlett, 1982; Ricci-Vitiani et al., 2008). Even though stem cells 
have an extensive capacity for self-renewal, in fact they remain quiescent most of the time 
and may undergo a limited number of self-renewing divisions in adult life (Cheshier et al., 
1999). This may be because, despite their proliferative capacity, stem cells often arrest at a 
G0-like cell cycle phase or checkpoint (Cheshier et al., 1999). In addition, the differentiation 
and self-renewal rates differ depending on the stem cell type (Ahn and Joyner, 2005; Hu et 
al., 2004).  
Adult stem cells are not easy to characterize. To date, adult stem cells have been characterize 
in vitro by using their differentiations patterns and cell surface markers. Stem cells have 
been identified in bone marrow, blood, the cornea and retina, the brain, skeletal muscle, 
dental pulp, liver, skin, the intestinal tract, pancreas, ovary, breast, lung, prostate and head 
and neck (http://stemcells.nih.gov/info/scireport). Thus, stem cells have been found in 
tissues that develop from all three embryonic germ layers.  
3. Signaling pathways in stem cells 
In both pluripotent and multipotent cells, self-renewal and cell fate decision are regulated 
by a complex set of factors and pathways. Each process: self-renewal and differentiation 
requires unique molecular programs specific to each pluripotent or multipotent cell. For 
example, in ESCs, self-renewal requires that the unique molecular program of the 
pluripotent state be maintained, whereas to differentiate into various lineages, ESCs must 
shift to alternative molecular programs that inhibit self-renewal and promote differentiation 
(Marson et al., 2008a). Understanding how cells switch between self-renewal and 
differentiation, and discovering which factors or signaling pathways control which daughter 
cell of an adult stem cell remains a stem cell and which undergoes differentiation, is crucial 
to understand the mechanism of tumorigenesis.  
Several “stemness” factors are required to ensure appropriate ESC behavior (pluripotency). 
A core network of factors, including transcription factors and RNA binding proteins (Oct4, 
Sox2, Nanog, Klf4, c-Myc, Tcf3, and Lin28), is involved in the circuits that regulate ESC 
pluripotency. (Marson et al., 2008a). Some of these regulatory factors are tissue or cancer 
specific; for example, Oct4 is expressed only in the inner cell mass of the embryo and not in 
the trophectoderm. Some of these key regulators of ESC identity, such as Oct4, Sox2, and 
Nanog are expressed only in specific human cancer types (Gidekel et al., 2003; Rodriguez-
Pinilla et al., 2007; Santagata et al., 2007). Thus, regulatory networks can determine classes of 
stem cells, such as ESCs, neural stem cells, or breast stem cells or other tissue specific stem 
cells (Muller et al., 2008). Sox2 and Nanog can also reprogram differentiated human cells 
into ESC-like induced pluripotent stem cells (Park et al., 2008; Wernig et al., 2007). 
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Pluripotency and the unlimited potential for self-renewal are the characteristics that 
distinguish ESCs from adult (tissue-specific) stem cells, which have more limited self-
renewal and tissue-specific differentiation potential. The common feature of stem cells (ESCs 
and adult stem cells) is self-renewal. Not surprisingly, the stem cell niche and signaling 
pathways such as Wnt/ǃ-catenin, Notch, Hedgehog TGF-ǃ, and Bmi-1 are involved in the 
regulation of normal self-renewal programs, the balance between self-renewal and 
differentiation (Dontu et al., 2004; Reya and Clevers, 2005; Schofield, 1978; Song et al., 2007; 
Taipale et al., 2002). Accumulating evidence indicates that  networks that balance proto-
oncogenes (promoting self-renewal) and tumor suppressors, which act as gatekeepers 
(limiting self-renewal) and caretakers (maintaining self-renewal) is also involved in tissue 
stem cell self-renewal programs (He et al., 2009). For example, the p53, PTEN, and INK4A 
pathways are involved in stem cell self-renewal (Armesilla-Diaz et al., 2009b; Cicalese et al., 
2009; Lowe and Sherr, 2003; Nagao et al., 2008; Zheng et al., 2008a) (Table 1). Therefore, it is 
not surprising that these transcription factors (PTEN, TP53 and INK4A) are deleted or 
mutated in multiple CSCs.  
 
Signaling 
pathway 
Type of stem or progenitor cell References 
Wnt/ 
ǃ-catenin 
Hematopoietic stem cells 
Epidermal stem cells 
Gastrointestinal stem cells 
Neural stem cells 
Embryonic stem cells 
Dental pulp stem cells 
(Luis et al., 2009; Reya et al., 2003) 
(Zhu and Watt, 1999) 
(Brittan and Wright, 2002; He et al., 2004) 
(Kalani et al., 2008) 
(Melchior et al., 2008; Tam et al., 2008) 
(Scheller et al., 2008) 
Notch Gastrointestinal progenitor cells 
Mammary stem/progenitor cells 
Liver stem cells 
Muscle progenitor cells 
 
Hematopoietic stem cells 
(Fre et al., 2005) 
(Bouras et al., 2008; Dontu et al., 2004) 
(Zong et al., 2009) 
(Buas and Kadesch, 2010; Conboy et al., 
2003; Conboy and Rando, 2002) 
(Varnum-Finney et al., 2000) 
Hedgehog Hematopoietic stem cells 
Neural stem cells 
 
Mammary stem cells 
(Bhardwaj et al., 2001) 
(Palma et al., 2005; Wechsler-Reya and 
Scott, 1999) 
(Liu et al., 2006) 
Bmi-1 Mammary stem cells 
Hematopoietic stem cells 
(Liu et al., 2006) 
(Park et al., 2003) 
PTEN Neural stem cells (Groszer et al., 2006; Groszer et al., 2001; 
Nagao et al., 2008; Zheng et al., 2008a)  
p53 Mammary stem cells 
Neural stem cells 
(Cicalese et al., 2009) 
(Armesilla-Diaz et al., 2009a; Zheng et al., 
2008a) 
Table 1. Signaling pathways involved in stem cell self-renewal. 
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Moreover, signaling pathways cross-talk or interact with each other to regulate stem cell 
behavior. For example, hypoxia-inducible factor-1ǂ and Notch signaling interact to regulate 
medulloblastoma precursor cell proliferation and differentiation (Pistollato et al., 2010). The 
Notch and EGFR pathways interact with each other to regulate the number of neural stem 
cells (NSCs) (Aguirre et al., 2010). Key pathways including Wnt, HH, Notch, and Bmi-1 and 
transcription factors including TP53 and PTEN are involved in the development of various 
organs during embryogenesis and in the regulation of self-renewal and differentiation in 
both normal adult stem cells (Molofsky et al., 2004), and CSCs such in normal adult SCs and 
CSCs in glioblastoma (Zheng et al., 2008b). Dysregulation of these core pathways (e.g. Wnt, 
HH, Notch) and transcription factors (TP53 and PTEN), which associated with normal stem 
cells is also plays a role in the cancer development (Zheng et al., 2008b). Here, we focus on 
the Wnt/ǃ-catenin, HH, and Notch pathways.  
3.1 Wnt/β-catenin pathway 
Two kinds of Wnt signaling pathways exist: the canonical Wnt pathway, in which Wnt 
ligands signal through the stabilization of ǃ-catenin, and the noncanonical Wnt pathway, 
which is ǃ-catenin-independent. The canonical Wnt pathway is activated when Wnt ligands 
bind to cell surface receptors composed of a member of the Frizzled protein family and one 
of the co-receptors LRP5 and LRP6 and hyperphosphorylate the Dishevelled (Dsh) protein, 
thereby activating it. Activation of Dsh prevents the phosphorylation of ǃ-catenin and 
inhibits the formation of ǃ-catenin destruction complex (glycogen synthase kinase 3β [GSK-
3β], adenomatous polyposis coli [APC], casein kinase 1α [CK1α] and Axin) which leads to 
the stabilization of hypophosphorylated ǃ-catenin and, thereby, to its translocation to the 
nucleus where it interacts with transcription factors (T cell factor/lymphoid enhancer factor 
[TCF/LEF]). Thus the β-catenin/TCF/LEF complex activates the transcription of target 
genes. In the absence of Wnt ligands, ǃ-catenin destruction complex hyperphosporylates β-
catenin, thereby this complex (hyperphosphorylated β-catenin, APC, Axin, GSK-3ǃ, and 
CK1ǂ) is thus a target for ubiquitination and degradation by the proteasome (Schweizer and 
Varmus, 2003). 
The noncanonical Wnt signaling pathway requires Frizzled receptors and the proteoglycan 
co-receptor Knypek. In this pathway, Dsh localizes in the cell membrane and activates Rho 
through Daam1. Dsh induce cellular response by stimulating calcium flux and activating the 
calcium-sensitive kinases protein kinase C and calmodulin-dependent protein kinase II 
(Veeman et al., 2003).  
Wnt signaling has been studied intensively in embryonic development. The response of cells 
to the Wnt pathway is tissue-dependent. Wnt signaling is involved in many key 
developmental processes, such as cell survival, proliferation, inhibition of apoptosis, stem 
cell maintenance, differentiation, and cell fate decision, and in the development of a variety 
of organ systems, including the cardiovascular system, central nervous system, kidney, and 
lung (Ille and Sommer, 2005; Peifer, 2000; Vainio et al., 1999a; Vainio et al., 1999b; Wodarz 
and Nusse, 1998). For example, the canonical Wnt pathway plays a crucial role in the 
development of intestinal tissue by regulating the self-renewal, migration and proliferation 
of intestinal stem and progenitor cells, and tissue self-renewal in hair follicles and bone 
growth plates (Clevers, 2006). The Wnt pathway also interacts with other pathways to 
regulate stem cell processes. For example, bone morphogenetic protein (BMP) inhibits Wnt 
signaling to negatively regulate stem cell proliferation (He et al., 2004),  BMP signaling 
thereby represses de novo crypt formation and polyp growth, and mutations in BMP 
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pathway genes lead to formation of crypts and generation of benign polyps (Reya and 
Clevers, 2005).  
In addition to biologic and developmental process, Wnt signaling is also involved in genetic 
processes. For example, APC has been shown to be involved in regulating mitotic spindle 
assembly, orientation of chromosomes during mitotic division, and chromosome 
segregation (Kaplan et al., 2001). Abnormalities in the orientation of chromosomes during 
mitotic division may contribute to numeric chromosomal aberrations in cancer cells (Peifer, 
2000).  
3.2 Hedgehog  pathway 
Three HH ligands have been identified—Sonic HH, Desert HH, and Indian HH (Cohen, 
2003). In the presence of ligands, these ligands bind to the transmembrane receptor Patched 
1 (Ptch 1), which inhibits Smothened (Smo). The binding of HH ligands relieves Smo 
inhibition, leading to activation of the Gli transcription factors Gli1 and Gli2 (activator) and 
Gli3 (suppressor). Activated Gli accumulates in the nucleus and controls the transcription of 
HH target genes. In the absence of HH ligands, Ptch1 inhibits Smo, and cannot activate Gli 
(Pasca di Magliano and Hebrok, 2003). The HH signaling pathway regulates cell 
proliferation through Cyclin D1 and FoxM1, apoptosis through Bcl-2, EMT through Snail 
and E-cadherin, and self-renewal through Bmi-1 (Kasper et al., 2009). Bmi-1 has been shown 
to be a key regulator of the self-renewal of NSCs and both normal and leukemic stem cells 
(Lessard and Sauvageau, 2003; Molofsky et al., 2003; Park et al., 2003). HH signaling has 
been shown to play a critical role in the development of many systems, including the limb, 
brain, spinal cord, thalamus, and teeth. The HH pathway is also important in cell 
proliferation, differentiation, and stem cell maintenance during embryogenesis (Ma et al., 
2002), and in the self-renewal and maintenance of NSCs (Ahn and Joyner, 2005; Lai et al., 
2003; Palma et al., 2005), mammary stem cells (Liu et al., 2006). 
Either aberration of genes in the HH signaling pathway or aberrant activation of HH 
signaling results in tumorigenesis. For example, germline mutations in Patch, which 
functions as a tumor suppressor has been found in basal cell carcinomas and Gorlin 
syndrome (Cohen, 2003). Activation of HH signaling is implicated in small cell lung cancer, 
digestive tract tumor, pancreatic carcinoma, breast cancer and prostate cancer (Karhadkar et 
al., 2004; Olsen et al., 2004).  
3.3 Notch pathway 
Members of the Notch gene family encode transmembrane receptors that are crucial for cell 
fate decision. Four Notch receptors (Notch1, Notch2, Notch3 and Notch4) and five ligands 
(Jagged-1 [JAG1] and JAG2, three Delta-like [DLL1, DLL2, and DLL4]) have been found. 
These receptors and ligands are expressed in different combinations in most cell types 
(Mumm and Kopan, 2000). After ligand binding, Notch receptors are activated via cleavages 
of ADAM metallopeptidase domain 17 (ADAM17) and presenilin-1, which result in the 
release and translocation of the Notch intracellular domain (NICD) to the nucleus and the 
activation of HES (Hes/E(spl) family) and HEY (Hesr/Hey family) families through 
interaction of NICD with sequence-binding protein (Mumm and Kopan, 2000). Notch 
signaling is crucial for arterial-venous differentiation, for self-renewal and differentiation in 
hematopoietic stem cells (Krause, 2002b), maintenance of the mammary stem cell population 
(Bouras et al., 2008), for adult neurogenesis (Androutsellis-Theotokis et al., 2006), and for the 
activity of myogenic muscle stem and progenitor cells (Buas and Kadesch, 2010; Conboy et 
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al., 2003; Conboy and Rando, 2002). Notch signaling is involved in the self-renewal process 
mostly in rapidly renewing tissues, such as the hematopoietic system (Mercher et al., 2008; 
Wu et al., 2007), the intestine, skin, highly proliferative ESCs, and the intestine, in which the 
epithelium is renewed every 4-5 days (Dontu et al., 2004). Notch and Wnt signaling 
cooperate to regulate self- renewal and cell fate in the adult intestine (Chiba, 2006; Fre et al., 
2005; Wang and Hou, 2010), and inhibition of Notch/Ǆ–secretase induces proliferation in 
intestinal crypt cells and the formation of polyps (van Es et al., 2005). Adult epidermal stem 
cells reside in the epidermal basal layer and in the bulge region of the hair follicle (Ambler 
and Maatta, 2009). In addition to differentiation and self-renewal, the Notch pathway is also 
involved in other developmental processes, including EMT, proliferation, apoptosis, and cell 
adhesion during embryogenesis (Zong et al., 2009).  
EMT was originally defined as a cellular reorganization process that is essential for 
embryonic development. EMT results in a loss of cell to cell adhesive properties, a loss of 
cell polarity, and a gain of the invasive and migratory features of mesenchymal cells (Thiery 
et al., 2009). During embryogenesis, EMT leads progenitor/precursor cells to migrate to 
distant sites within the embryo to form new tissues (Shook and Keller, 2003). The EMT 
process is reversible. EMT also occurs during tumorigenesis; the process is similar to EMT 
during the embryogenesis, but instead of forming new tissue, it allows some CSCs to 
become metastatic while keeping the features of the original tissue. It is not surprising that, 
the same, or similar, core signaling pathways (Wnt, HH and Notch) that regulate stem cell 
self-renewal are also involve regulation of EMT together as are niche factors (Mani et al., 
2008; Vincan and Barker, 2008; Yang and Weinberg, 2008).  
The dysregulation of signaling pathways by mutations and/or by genomic and epigenetic 
aberrations, which are involved in the regulation of stem cell function as well as in EMTs 
during embryonic development may play a crucial role in the development of cancer. CSCs 
and normal stem cells use many of the same signaling pathways, such as Wnt, HH, and 
Notch, but the difference is CSC use dysregulated way of these signaling pathways (Takebe 
et al., 2010). Upto now, aberrant Notch signaling has been shown in multiple human cancers 
including hepatocellular carcinoma, hepatoblastoma, colorectal cancer, acute myeloid 
leukemia, chronic myeloid leukemia, multiple myeloma, gastric cancer, and Wilms’ tumor 
which also shows dysregulation of Wnt signaling (de La Coste et al., 1998; Kim et al., 2009; 
Koesters et al., 1999; Martin et al., 2010 ; Reya and Clevers, 2005) (Table 2). 
4. Cancer stem cells 
Normal stem cells and CSCs share several important properties, including the ability to self-
renew. The signaling pathways and transcription factors that are involved in the self-
renewal of normal stem cells have all been implicated in the development of cancers, but in 
CSCs the pathways are dysregulated and the factors are aberrantly expressed. CSCs can be 
distinguished from normal stem cells by the following. 
1. CSCs have the capacity for self-renewal like normal stem cells, but CSCs have a 
different self-renewal rate from normal stem cells. 
2. CSCs have the capacity to differentiate into cells of the specific tissue, but aberrantly 
(Singh et al., 2003). 
3. CSCs have the ability to develop tumor when transplanted into the proper 
environment. 
4. CSCs have the capacity for tumor metastasis. 
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5. CSCs have the abilty to repopulate the tumor, causing relapse, and can become resistant 
to different therapeutic agents. 
6. CSCs are identified by characteristic cell surface markers. 
Aberrant activation of an individual signaling pathway or cross-talk between pathways may 
result in tissue-specific carcinogenesis (Sun et al., 2010). Thus, an understanding of the 
pathways that govern the self-renewal and cell fate decisions of normal stem cells, and how 
these pathways are dysregulated and which of them are dysregulated during 
carcinogenesis, is of utmost importance. In many cases, self-renewal regulators have 
surprisingly similar functions in CSCs and normal stem cells (Tables 1 and 2). For example, 
 
Signaling 
pathway 
Type of cancer References 
Wnt/ 
β-catenin 
Liver 
Breast 
Chronic myeloid leukemia 
Acute myeloid leukemia 
Colon 
Prostate 
Intestine 
Skin 
(Ma et al., 2007) 
(Korkaya et al., 2009) 
(Zhao et al., 2007) 
(Wang et al., 2010) 
(Polakis, 2000; Vermeulen et al.) 
(Bisson and Prowse, 2009; Shahi et al., 2011) 
(Fre et al., 2009) 
(Chan et al., 1999) 
Notch Liver 
Colon 
Breast 
Intestine 
Prostate 
T-cell leukemia 
(Ma et al., 2007) 
(Sikandar et al., 2010) 
(Bouras et al., 2008; Dontu et al., 2004) 
(Fre et al., 2009) 
(Shahi et al., 2011) 
(Aster et al., 2010) 
Hedgehog Liver 
Breast 
Pancreatic 
Glioblastoma 
Chronic myeloid leukemia 
Colon 
Multiple myeloma 
Medulloblastoma 
Basal cell carcinoma 
(Ma et al., 2007) 
(Liu et al., 2006) 
(Li et al., 2007) 
(Ingham, 2008) 
(Dierks et al., 2008; Zhao et al., 2009) 
(Varnat et al., 2009) 
(Peacock et al., 2007) 
(Berman et al., 2002) 
(Gailani and Bale, 1999) 
Bmi-1 Breast 
Head and neck squamous 
cell cancer 
Acute myeloid leukemia 
(Liu et al., 2006) 
(Prince et al., 2007) 
 
(Lessard and Sauvageau, 2003) 
PTEN Breast 
Glioblastoma 
(Korkaya et al., 2009) 
(Zheng et al., 2008b) 
Table 2. Signaling pathways that are involved in stem cell self-renewal and are dysregulated 
in cancer stem cells 
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the proto-oncogene Bmi-1 is required to maintain both the proliferative potential of 
leukemic stem cells (Lessard and Sauvageau, 2003) and the self-renewal potential of normal 
hematopoietic stem cells, mammary stem cells, and NSCs (Liu et al., 2006; Molofsky et al., 
2003; Park et al., 2003). Similarly, PTEN and TP53 are required for differentiation and to 
maintain self-renewal not only in normal NSCs but also in neoplastic stem cells of 
glioblastoma (Zheng et al., 2008a; Zheng et al., 2008b). Notch signaling is also required to 
maintain self-renewal in normal and glioma stem cells (Hu et al., 2011), and HH signaling is 
required not only for normal NSC maintenance but also for brain tumor cell proliferation 
(Balordi and Fishell, 2007). 
Whereas some key transcription factors share some of their target genes and participate in 
autologous feedback loops to control one another’s transcription, others directly regulate 
self-renewal. On the other hand, in addition to key transcription factors and RNA-binding 
proteins that regulate self-renewal, miRNAs are also involved in this complex regulatory 
network.  
5. miRNAs 
Small noncoding RNAs, which include miRNAs, are a new class of gene that do not code 
mRNA or protein but are post-transcriptional regulators of gene expression. This regulation 
generally occurs by binding of a small ( ~22-nucleotide-long) mature miRNA to mRNA via 
direct canonical base-pairing between nucleotides 2–8 at the 5′ end of the miRNA (the seed 
region) and the 3′ untranslated region (UTR) of the target mRNA (its complementary seed-
match sequence). Mature single-stranded miRNA is unwound by the helicase activity of 
Dicer and the RNA-induced silencing complex, resulting in the inhibition of translation, 
destabilization, and localization of target mRNA. miRNAs are not only post-transcriptional 
regulators of target genes but also play roles in establishing epigenetic programs (Filipowicz 
et al., 2008; Stefani and Slack, 2008). miRNAs are not translated into protein, rather, their 
function is to regulate gene expression by binding to other RNAs, particularly mRNA 
(Bartel, 2004) (Table 3). 
The first miRNAs were discovered in Caenorhabditis elegans when mutations in lin-4 (Lee et 
al., 1993) and let-7 (Reinhart et al., 2000) were found to result in defective stem cell 
maturation (Bartel, 2004). Since then, the miRNA field has been explored extensively and 
miRNAs have been found to be key regulators of many gene expression networks. In 
humans, thousands of miRNAs regulate thousands of mRNAs, and each miRNA targets 
and regulates hundreds of mRNAs to either induce their degradation or prevent their 
translation. Accumulating data have shown that miRNAs are involved in almost every 
biological process, and therefore dysregulation of miRNAs is involved in many human 
diseases, most notably cancer (Esquela-Kerscher and Slack, 2006; Yu et al., 2007) (Table 4). 
miRNAs play crucial roles as regulators of stem cell function, differentiation, and embryonic 
development (Filipowicz et al., 2008; Stefani and Slack, 2008), as well as act as oncogenes 
and tumor suppressor genes (Garzon et al., 2006). Recent discoveries have revealed that a 
complex regulatory network of miRNAs, transcription factors, and signaling pathways 
orchestrate cell-renewal and differentiation (Ferretti et al., 2008; Kato et al., 2009; Kennell et 
al., 2008; Marson et al., 2008b). The switch from pluripotent to lineage-specific cells is 
characterized by suppression of pluripotency by activation of expression of lineage-specific 
genes and repression of self-renewal genes in ESCs, and miRNAs are involved in the 
regulation of genetic programs. For example, miR-145 promotes the switch from the 
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Target 
Effect 
(positive or 
negative) 
miRNA 
Biological 
process 
References 
I. Wnt signaling 
β-catenin – miR-200a Meningioma (Saydam et al., 2009) 
APC – miR-135a, miR-135b Colorectal cancer (Nagel et al., 2008) 
Wnt1  miR-34a, miR-21 
Dendritic cell 
differentiation 
(Hashimi et al., 2009) 
II. Hedgehog signaling 
Smoothened 
(Smo) 
+ 
miR-324-5p 
miR-125b 
miR-326 
Neural stem cell 
proliferation, 
medulloblastoma
(Ferretti et al., 2008) 
Gli1 + & – miR-324-5p 
Neural stem cell 
proliferation, 
medulloblastoma
(Ferretti et al., 2008) 
Dkk1 
Kremen2 
SFRP2 
+ miR-29 
Osteoblast 
differentiation 
(Kapinas et al., 2010) 
III. Receptor tyrosine kinase signaling 
NRAS, KRAS – let-7 
Cancer stem cell 
differentiation, 
tumor formation
(Johnson et al., 2005) 
IV. Notch signaling 
HES1 – miR-159b-5p Medulloblastoma (Garzia et al., 2009) 
JAG1 – miR-34a, miR-21 
Dendritic cell 
differentiation 
(Hashimi et al., 2009) 
JAG1 – miR-200 
Pancreatic 
adenocarcinoma
Basal-type breast 
cancer 
(Brabletz et al., 2011) 
Notch1 
JAG1 
– miR-34a 
Cervical 
carcinoma 
(Pang et al., 2010) 
LATS + miR-372, miR-373 
Testicular germ 
cell tumor 
(Voorhoeve et al., 2006) 
V. p53 signaling 
TP53 + miR-125b 
Apoptosis in the 
brain 
(Le et al., 2009) 
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Target 
Effect 
(positive or 
negative) 
miRNA 
Biological 
process 
References 
VI. PTEN signaling 
PTEN 
Bim 
Prkaa1 
PP2A 
– miR-19 
T-cell acute 
lymphoblastic 
leukemia 
(Mavrakis et al., 2010) 
PTEN – miR-21 
Hepatocellular 
cancer 
(Meng et al., 2007) 
Table 3. MicroRNAs that regulate signaling pathways that determine properties of cancer 
stem cells 
pluripotent state to lineage-specific differentiation by supressing pluripotency factors (e.g., 
Klf4, Sox2, and Oct4) (Xu et al., 2009). Similarly, the switch from multipotent to lineage 
specific cells is marked by inhibition of self-renewal and proliferation and induction of cell 
fate decision. For example, miR-124 promotes neuronal differentiation by downregulating 
Sox9 in adult neural stem cells (Cheng et al., 2009). miRNAs that are involved in stem cell 
self-renewal and differentiation and thus regulate cell type specification and differentiation 
are summarized in Table 3. 
Recent reports indicate that miRNAs are central players in stem cell biology (Gangaraju and 
Lin, 2009), and may have a crucial role in future stem cell therapies. Each type of cell has a 
distinct miRNA signature. For example, Suh and colleagues reported the first miRNA 
signature in human ESCs and grouped those miRNAs into four classes; (1) miRNAs found 
to be specific to ESCs (miR-154, miR-200c, miR-368, miR-371, miR-372, and miR-373); (2) 
miRNAs found in both ESCs and their malignant counterpart, embryonal carcinoma cells 
(miR-302a, miR-302b, miR-302c, miR-302d, and miR-367); (3) miRNAs found to be rare in 
ESCs but abundant in HeLa and STO cells (let-7a, , miR-21, miR-29, miR-29b, miR-301, and 
miR-374); and (4) miRNAs found to be expressed in most of the cell lines tested (miR-16, 
miR-17-5p, miR-19b, miR-26a, miR-92, miR-103, miR-130a, and miR-222) (Suh et al., 2004). 
 
miRNA Type of cell Biological process References 
let-7 Breast cancer stem cells Self-renewal (Yu et al., 2007) 
let-7 Breast cancer stem cells Differentiation (Yu et al., 2007) 
let-7a-1 
let-7d 
let-7-f-1 
ESCs Pluripotency (Navarro et al., 2009) 
let-7a-2 
let-7a-3,  
let-7b 
ESCs Pluripotency (Navarro et al., 2009) 
miR-92a ESC Self-renewal and 
differentiation 
(Sengupta et al., 2009) 
miR-124 Adult neuronal stem 
cell 
Differentiation (Cheng et al., 2009) 
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miRNA Type of cell Biological process References 
miR-200 
miR-205 
ESCs Epithelial–
mesenchymal 
transition 
(Bracken et al., 2008; 
Gregory et al., 2008) 
miR-150 B cells Differentiation (Xiao et al., 2007) 
miR-1 Myoblasts Differentiation (Chen et al., 2006) 
miR-430 
miR-427 
miR-302 
ESCs Repress formation of 
ectoderm progenitor 
cells 
(Ivey and Srivastava, 
2010) 
miR-109 
miR-24 
ESCs Repress formation of 
endoderm progenitor 
cells 
(Ivey and Srivastava, 
2010) 
miR-122 
miR-192 
ESCs Promote formation of 
endoderm progenitor 
cells 
(Ivey and Srivastava, 
2010) 
miR-17-92 
miR-15a 
miR-16-1 
miR-21 
ESCs Self-renewal (Navarro et al., 2009) 
miR-199a Mesoderm progenitor 
cells 
Repress differentiation 
into chondrocytes 
(Ivey and Srivastava, 
2010) 
miR-296 
miR-2861 
Mesoderm progenitor 
cells 
Promote differentiation 
into osteoblasts 
(Ivey and Srivastava, 
2010) 
miR-214 
miR-206 
miR-1 
miR-26a 
Mesoderm progenitor 
cells 
Promote differentiation 
into skeletal muscle 
cells 
(Ivey and Srivastava, 
2010; Chen et al., 
2006) 
miR-133 
miR-221 
miR-222 
Mesoderm progenitor 
cells 
Repress differentiation 
into skeletal muscle 
cells 
(Ivey and Srivastava, 
2010) 
miR-1 
 
Mesoderm progenitor 
cells 
Promote differentiate 
into cardiac muscle 
cells 
(Ivey and Srivastava, 
2010) 
miR-133 Mesoderm progenitor 
cells 
Repress differentiation 
into cardiac muscle 
cells 
(Ivey and Srivastava, 
2010) 
miR-145 Neural crest stem cells Promote differentiation 
into smooth muscle 
cells 
(Ivey and Srivastava, 
2010) 
miR-203 Ectoderm progenitor 
cells 
Promote differentiation 
into keratinocytes 
(Ivey and Srivastava, 
2010) 
miR-9 
miR-124a 
Neural stem cells Promote differentiation 
into glial cells and 
neurons 
(Ivey and Srivastava, 
2010) 
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miRNA Type of cell Biological process References 
miR-223 
miR-181 
Hematopoietic 
progenitor cells 
Promote differentiation 
into lymphoid 
progenitor cells 
(Ivey and Srivastava, 
2010) 
miR-223 Hematopoietic 
progenitor cells 
Promote differentiation 
into myeloid 
progenitor cells 
(Ivey and Srivastava, 
2010) 
miR-146 
miR-128a 
miR-181a 
Hematopoietic 
progenitor cells 
Repress differentiation 
into lymphoid 
progenitor cells 
(Ivey and Srivastava, 
2010) 
miR-128a 
miR-181a 
miR-155 
miR-24a 
miR-17 
Hematopoietic 
progenitor cells 
Repress differentiation 
into myeloid 
progenitor cells 
(Ivey and Srivastava, 
2010) 
miR-150 Lymphoid progenitor 
cells 
Promote differentiation 
into T cells 
(Ivey and Srivastava, 
2010) 
miR-223 Myeloid progenitor 
cells 
Repress differentiation 
into granulocytes 
(Ivey and Srivastava, 
2010) 
miR-17-5p 
miR-20a 
miR-106a 
Myeloid progenitor 
cells 
Repress differentiation 
into monocytes 
(Ivey and Srivastava, 
2010) 
miR-150 
miR-155 
miR-221 
miR-222 
Myeloid progenitor 
cells 
Repress differentiation 
into red blood cells 
(Ivey and Srivastava, 
2010) 
miR-451 
miR-16 
Myeloid progenitor 
cells 
Promote differentiation 
into red blood cells 
(Ivey and Srivastava, 
2010) 
miR-355 Mesenchymal stem cells Repress proliferation 
and migration 
(Ivey and Srivastava, 
2010) 
miR-92a ESC Repress G1–S transition (Sengupta et al., 2009) 
miR-372 
miR-195 
ESC 
ESC 
Repress G1–S transition 
Repress G2–M 
transition 
(Qi et al., 2009) 
Table 4. miRNAs involved in self-renewal and differentiation processes in normal stem cells 
and cancer stem cells. 
Nanog, Oct4, and Sox2 have been found to be key regulators of ESC pluripotency. miR-134, 
miR-296, and miR-470 have been shown to modulate ESC pluripotency by regulating 
Nanog, Oct4, and Sox2, which are key regulators of ESC pluripotency (Tay et al., 2008). 
Recent studies have identified two groups of miRNAs: markers of pluripotency, which are 
expressed in the undifferentiated state (miR-200c, miR-371, miR-372, miR-302a, miR-320d, 
miR-373, miR-302c, miR-21, miR-222, miR-296, miR-494, and miR-367) and miRNAs that 
regulate the differentiation of cells into one of the different lineages (miR-17, miR-92, and 
miR-93, which are overexpressed in differentiated cells; and miR-154, miR-29a, miR-143, 
miR-29c, and let-7a, which are underexpressed in differentiated cells) (Lakshmipathy et al., 
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2007). miR-302d and miR-372 target the transcription factors TRPS1 and KLF13 and the 
RNA binding protein MBNL2 to regulate ESC self-renewal (Li et al., 2009).  
miRNAs of the let-7 family (let-7a-1, let-7a-2, let-7a-3, let-7b, let-7c, let-7d, let-7e, let-7f-1, let-
7f-2, let-7g, let-7i and miR-98) are key regulators of self-renewal and proliferation and act as 
tumor suppressors. Numerous genes that promote the G1/S or G2/M transition, such as 
CDK6, CDC25A, and CCND2, are direct targets of let-7. Let-7 also negatively regulates 
oncogenes such as NRAS, KRAS, HMGA2, and c-Myc, and pluripotency-regulating genes 
such as Lin28 (Chivukula and Mendell, 2008). Let-7 modulates self-renewal by targeting 
HRAS and differentiation by targeting HMGA2 in breast cancer cells (Yu et al., 2007). 
Expression of the let-7 family of miRNAs has been found to be downregulated both in 
embryonic lung tissue and in lung tumors (Navarro et al., 2009), colon cancer (Akao et al., 
2006), and breast cancer (Iorio et al., 2005). Moreover, let-7 has been shown to be 
downregulated in ESCs and high during differentiation, in which LIN28 expression is high 
in ESC, but decreases during differentiation (Marson et al., 2008b). Let-7 and LIN28 form a 
tight feedback loop that is fundamental for stem cell self-renewal and differentiation 
(Gunaratne, 2009; Martinez and Gregory, 2010). miR-150 regulates differentiation by 
targeting c-Myb in B-cells (Xiao et al., 2007), while miR-1 regulates differentiation by 
targeting Mef2c in myoblasts (Chen et al., 2006). miRNAs regulate self-renewal in ESC by 
controlling the G1-S and G2-M transition. For example, miR-92a is a negative regulator of 
G1-S transition by targeting CDKN1C (Sengupta et al., 2009). miR-372 targets CDKN1A to 
negatively regulate G1-S transition, while miR-195 negatively regulates G2-M transition by 
targeting WEE1 in ESCs (Qi et al., 2009). miR-125b, miR-504, miR-25 and miR-30d directly 
target and negatively regulate TP53 (Kumar et al., 2011). 
The following miRNAs have been found to be key regulators of EMT: miR-200a, miR-200b, 
miR-200c, miR-141, and miR-429 (Gregory et al., 2008). The miR-200 family regulates EMT 
by targeting different genes. For example, miR-200b, miR-141 and miR-205 target ZEB2 
(Gregory et al., 2008), miR-141 and miR-155 targets TGF-ǃ2 (Bracken et al., 2008; Burk et al., 
2008), miR-200a targets ZEB2 and CTNNB1 (Xia et al., 2010) to regulate EMT. In addition, 
miR-335 has been found to regulate differentiation, proliferation, and migration in 
mesenchymal stem cells (Tome et al., 2011).  
6. Conclusion 
In the past decade, tremendous progress has been made in discovering molecular 
mechanisms  (signaling pathways, transcription factors and miRNAs) that regulate stem 
cell self-renewal and differentiation, but many questions remain to be answered. For 
example, which factors and signaling pathways determine which daughter cell of an adult 
stem cell remains a stem cell and which undergoes differentiation. How do cells decide 
whether to self-renew? How do cells decide whether to migrate to develop organs during 
embryogenesis, and how do cells decide when that specific organogenesis process is 
complete? How do cells decide to stop proliferating? Which regulatory factors are 
involved in normal cell differentiation, and which factors are aberrantly expressed in 
cancer?   
New discoveries will add to our understanding of the balance between self-renewal and 
differentiation in normal stem cells and, therefore, provide new insights into development 
and progression of cancer, which may lead to the development of more effective molecular 
cancer therapies. Most current cancer therapeutic agents aim to kill cancer cells. These 
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therapeutic agents kill cancer cells as well as normal cells, but do not kill CSCs. A more 
effective approach to the treatment of cancer may be to use therapeutic agents that block 
self-renewal and that induce cell to complete differentiation instead of killing cells. Since 
miRNAs are key regulators in self-renewal and differentiation, thereby miRNAs can be used 
as potential therapeutic agents or targets. 
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